FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 11/16/2020 |
3. Issuer Name and Ticker or Trading Symbol
DELTA AIR LINES, INC. [ DAL ] |
|||||||||||||
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
|
Table I - Non-Derivative Securities Beneficially Owned | |||
---|---|---|---|
1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock | 14,313(1) | D |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
---|---|---|---|---|---|---|---|
1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Employee Stock Option (right to buy) | (2) | 02/01/2027 | Common Stock | 9,390 | $49.33 | D | |
Employee Stock Option (right to buy) | (3) | 02/07/2028 | Common Stock | 12,140 | $51.23 | D | |
Employee Stock Option (right to buy) | (4) | 02/05/2029 | Common Stock | 11,110 | $50.52 | D |
Explanation of Responses: |
1. Represents shares of restricted common stock. Of these restricted shares, (i) 2,733 were granted to the Reporting Person on February 8, 2018 and will vest on February 1, 2021, (ii) 4,440 were granted to the Reporting Person on February 6, 2019 and will vest in two equal installments on February 1, 2021 and 2022 and (iii) 7,140 were granted on February 5, 2020 and will vest in three equal installments on February 1, 2021, 2022 and 2023. The grants of restricted stock were approved by the Personnel & Compensation Committee ("P&C Committee") of Delta's Board of Directors and are exempt from Section 16(b) of the Securities Exchange Act of 1934 ("Exchange Act") under Rule 16b-3(d). |
2. On February 9, 2017, the P&C Committee granted to the Reporting Person an option to purchase 9,390 shares of common stock. The option vested subject to Delta's satisfaction of certain performance criteria, which were certified by the P&C Committee on February 8, 2018. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d). |
3. On February 8, 2018, the P&C Committee granted to the Reporting Person an option to purchase 12,140 shares of common stock. The option vests subject to Delta's satisfaction of certain performance criteria. Because the performance criteria were met, as certified by the P&C Committee on February 6, 2019, the option as to 8,094 shares has vested; the option for the remaining 4,046 shares will vest on February 1, 2021. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d). |
4. On February 6, 2019, the P&C Committee granted to the Reporting Person an option to purchase 11,110 shares of common stock. The option vests subject to Delta's satisfaction of certain performance criteria. Because the performance criteria were met, as certified by the P&C Committee on February 5, 2020, the option as to 3,704 shares has vested; the option for the remaining 7,406 shares will vest in two equal installments on February 1, 2021 and 2022. This grant was approved by the P&C Committee and is exempt from Section 16(b) of the Exchange Act under Rule 16b-3(d). |
Remarks: |
Co-CFO, SVP, Business Development & Financial Planning |
/s/ Stephanie W. Bignon as attorney-in-fact for Garrett L. Chase | 11/24/2020 | |
** Signature of Reporting Person | Date | |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. |